Sharpe ratio
0.99Return earned for the risk taken.
Moderate
Moderate risk-adjusted returns. The reward for risk has been average.
+27.91%1Y Absolute Return
-0.27%1D
Loading NAV history…
Past performance is not an indicator of future returns.
Returns calculator comparison
Compare an illustrative investment outcome across return assumptions.
| Asset | Projected corpus | Total invested | Gain | Annual return |
|---|---|---|---|---|
| Mirae Asset Healthcare Fund Direct GrowthFund 5Y annualised return | ₹11,49,360 | ₹7,32,612 | ₹4,16,748 | +17.89% |
| EPFIllustrative annual assumption | ₹8,95,132 | ₹7,32,612 | ₹1,62,520 | +8.25% |
| Residential propertyIllustrative annual assumption | ₹8,67,662 | ₹7,32,612 | ₹1,35,050 | +7.00% |
| PPFIllustrative annual assumption | ₹8,69,819 | ₹7,32,612 | ₹1,37,207 | +7.10% |
| Bank fixed depositIllustrative annual assumption | ₹8,56,981 | ₹7,32,612 | ₹1,24,369 | +6.50% |
| GoldIllustrative annual assumption | ₹8,67,662 | ₹7,32,612 | ₹1,35,050 | +7.00% |
| Savings accountIllustrative annual assumption | ₹7,86,827 | ₹7,32,612 | ₹54,215 | +3.00% |
Illustration only. Fund results use the available NAV-derived annualised return and can be negative. Reference rows are assumptions, not current quoted rates or guaranteed returns; property excludes transaction costs, taxes, and liquidity constraints. Mutual fund investments are subject to market risk.
Wealth multiple
₹1 became₹1.23
₹1 Lakh since launch₹1.23 Lakh
Fund age8.4 yrs
Fund information
Scheme code143783
ISININF769K01ED6
BenchmarkBSE Healthcare TRI
CategoryEquity Scheme - Sectoral/ Thematic
Expense ratio0.61%
Exit loadExit load of 1% if redeemed within 1 Month.
Minimum SIP₹99 SIP
Return comparison
13th / 932 in category| Period | Fund | Benchmark | Category avg |
|---|---|---|---|
| 1M | +245.36% | — | — |
| 3M | +32.96% | — | — |
| 6M | +34.80% | — | — |
| 1Y | +27.91% | — | +4.16% |
| 3Y | +24.44% | — | +12.54% |
| 5Y | +17.89% | — | +10.04% |
| Since Launch | +22.59% | — | — |
Risk-adjusted performance
Every measure is expanded with a plain-language reading of the latest calculated value.
Sortino ratio
1.47Return earned while limiting downside risk.
Good
Good downside protection with strong returns.
Standard deviation
14.13%How much the fund’s returns fluctuate over time.
Moderate volatility
Returns can move up and down noticeably.
Beta
—How closely the fund moves with the market.
Unavailable
This measure needs sufficient fund and benchmark history to calculate.
Alpha
—Extra return generated above the benchmark.
Unavailable
This measure needs sufficient fund and benchmark history to calculate.
Treynor ratio
—Return earned for each unit of market risk taken.
Unavailable
This measure needs sufficient fund and benchmark history to calculate.
Calmar ratio
1.13How well the fund rewarded investors relative to its biggest decline.
Excellent
Excellent balance between returns and drawdowns.
Information ratio
—How consistently the fund outperformed its benchmark.
Unavailable
This measure needs sufficient fund and benchmark history to calculate.
Portfolio allocation
Latest disclosed portfolio mix
Asset allocation
Allocation data has not been disclosed.
Market cap allocation
Sector allocation
Equity exposure by sector
Top holdings
10 of 30 disclosed positions
| Holding | Sector | Instrument type | Weight |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 11.0568% |
| Divi's Laboratories Ltd | Healthcare | Equity | 8.7102% |
| Torrent Pharmaceuticals Ltd | Healthcare | Equity | 7.4738% |
| Apollo Hospitals Enterprise Ltd | Healthcare | Equity | 5.9404% |
| Glenmark Pharmaceuticals Ltd | Healthcare | Equity | 5.5272% |
| Laurus Labs Ltd | Healthcare | Equity | 5.1324% |
| Aurobindo Pharma Ltd | Healthcare | Equity | 3.8249% |
| Alkem Laboratories Ltd | Healthcare | Equity | 3.5571% |
| Fortis Healthcare Ltd | Healthcare | Equity | 3.5499% |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | Equity | 3.4753% |
Fund management
VR
Vrijesh Kasera
Since 2018 · Prior to joining Mirae Asset Mutual Fund, he was associated with Axis Capital Ltd. as an Equity Research Analyst. He has also been associated with Edelweiss Broking Ltd.
Mr. Kasera is a MBA (Finance), CFA (ICFAI).
TA
Tanmay Mehta
Since 2025 · Prior to joining the Mirae asset MF, he was associated with SBI capital markets.
B.Com, C.A.
Compare similar funds
No comparable category funds are available yet.
Summary
A high riskometer-risk equity scheme - sectoral/ thematic fund. Ahead of its category average over 3Y by 11.9 points. Healthcare makes up 98% — trouble in that sector hits the whole fund.
Strengths
- Ahead of its category average over 3Y by 11.9 points.
- Turned every ₹1 into ₹5.5 since launch — compounding at 22.6% a year.
- Losses and swings stayed contained — worst fall -20.0%, volatility 14.1%.
- Recovered from its worst fall in 0 months.
- Same fund manager for 8+ years — the strategy has not chopped and changed.
- Ranks 13 of 932 in its category over 1 year.
Weaknesses
- None
Ideal investor
- Needs a 5–7+ years horizon to ride out its high riskometer risk level.
- Good fit for SIPs — spreading purchases smooths out 14.1% volatility.
Risk drivers
- Healthcare makes up 98% — trouble in that sector hits the whole fund.